866-997-4948(US-Canada Toll Free)

Psoriasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency Market Research

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 200 Pages

Psoriasis Treatment Market - Scope of the Report

TMR’S report on the global psoriasis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global psoriasis treatment market for the period of 2017–2027, considering 2018 as the base year and 2027 as the forecast end-year. The report also provides the compound annual growth rate (CAGR) for the global psoriasis treatment market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global psoriasis treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global psoriasis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global psoriasis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global psoriasis treatment market. The next section of the global psoriasis treatment report highlights the USPs, which include regulatory scenarios for psoriasis treatment, globally, psoriasis treatment pipeline analysis, and potential mergers & acquisition in the global psoriasis treatment market.

The report delves into the competitive landscape of the global psoriasis treatment market. Key players operating in the global psoriasis treatment market have been identified, and each one of these have been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOT are some of the attributes of the players profiled in the global psoriasis treatment market report.

Key Questions Answered in Global Psoriasis Treatment Market Report

  • What is the sales/revenue expected to be generated by psoriasis treatment products across all the regions during the forecast period?
  • What are the key trends in the psoriasis treatment market?
  • What are the major drivers, restraints, and opportunities in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue, globally, in 2027, and which product will expand at the fastest CAGR during the forecast period?

Psoriasis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global psoriasis treatment market begins with an overview of the said market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of this study, and the healthcare compliances laid down by accredited agencies in the purview of research. It is followed by market introduction, market dynamics, and an overview of the global psoriasis treatment market, which includes TMR’s analysis of the market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights have been provided to understand the Y-o-Y trends of the psoriasis treatment market. The next section of the global psoriasis treatment report highlights the USPs, which include regulatory scenarios for psoriasis treatment, globally, psoriasis treatment pipeline analysis, and key mergers & acquisitions in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of the key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key psoriasis treatment market manufacturers have been mapped to ascertain the size of the global psoriasis treatment market in terms of value. The forecasts presented here assess the total revenue generated in the psoriasis treatment market. In order to provide an accurate forecast, we initiated by sizing up the current psoriasis treatment market with the help of the parent market.

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Psoriasis Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Psoriasis Treatment Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Regulatory Scenario by Region/Key Country 

5.2. Psoriasis Treatment Market Pipeline Analysis 

5.3. Key Mergers & Acquisitions 

6. Global Psoriasis Treatment Market Analysis and Forecast, by Drug Class 

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

6.3.1. TNF Inhibitors

6.3.2. Interleukin Inhibitors

6.3.3. Vitamin D Analogs

6.3.4. Corticosteroids

6.3.5. Others

6.4. Market Attractiveness, by Drug Class 

7. Global Psoriasis Treatment Market Analysis and Forecast, by Route of Administration 

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

7.3.1. Oral

7.3.2. Parenteral

7.3.3. Topical 

7.4. Market Attractiveness By Route of Administration 

8. Global Psoriasis Treatment Market Analysis and Forecast, by Distribution Channel 

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Others

8.4. Market Attractiveness, by Distribution Channel

9. Global Psoriasis Treatment Market Analysis and Forecast, by Region 

9.1. Key Findings

9.2. Psoriasis Treatment Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe 

9.2.3. Asia Pacific

9.2.4. Latin America 

9.2.5. Middle East & Africa

9.3. Market Attractiveness, by Region

10. North America Psoriasis Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

10.2.1. TNF Inhibitors

10.2.2. Interleukin Inhibitors

10.2.3. Vitamin D Analogs

10.2.4. Corticosteroids

10.2.5. Others

10.3. North America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

10.3.1. Oral

10.3.2. Parenteral

10.3.3. Topical 

10.4. North America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Others 

10.5. North America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Psoriasis Treatment Market Attractiveness Analysis

10.6.1. By Drug Class

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country

11. Europe Psoriasis Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.1.2. Others

11.2. Europe Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

11.2.1. TNF Inhibitors

11.2.2. Interleukin Inhibitors

11.2.3. Vitamin D Analogs

11.2.4. Corticosteroids

11.2.5. Others

11.3. Europe Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

11.3.1. Oral

11.3.2. Parenteral

11.3.3. Topical 

11.4. Europe Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Others 

11.5. Europe Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Psoriasis Treatment Market Attractiveness Analysis

11.6.1. By Drug Class

11.6.2. By Route of Administration

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Psoriasis Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

12.2.1. TNF Inhibitors

12.2.2. Interleukin Inhibitors

12.2.3. Vitamin D Analogs

12.2.4. Corticosteroids

12.2.5. Others

12.3. Asia Pacific Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

12.3.1. Oral

12.3.2. Parenteral

12.3.3. Topical 

12.4. Asia Pacific Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Others 

12.5. Asia Pacific Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Psoriasis Treatment Market Attractiveness Analysis

12.6.1. By Drug Class

12.6.2. By Route of Administration

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Psoriasis Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

13.2.1. TNF Inhibitors

13.2.2. Interleukin Inhibitors

13.2.3. Vitamin D Analogs

13.2.4. Corticosteroids

13.2.5. Others

13.3. Latin America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

13.3.1. Oral

13.3.2. Parenteral

13.3.3. Topical 

13.4. Latin America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Others 

13.5. Latin America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Psoriasis Treatment Market Attractiveness Analysis

13.6.1. By Drug Class

13.6.2. By Route of Administration

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa Psoriasis Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

14.2.1. TNF Inhibitors

14.2.2. Interleukin Inhibitors

14.2.3. Vitamin D Analogs

14.2.4. Corticosteroids

14.2.5. Others

14.3. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

14.3.1. Oral

14.3.2. Parenteral

14.3.3. Topical 

14.4. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Others 

14.5. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis

14.6.1. By Drug Class

14.6.2. By Route of Administration

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Share Analysis, by Company, 2018

15.2. Company Profiles

15.2.1. Amgen, Inc.

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Financial Overview

15.2.1.3. Product Portfolio

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Eli Lilly and Company

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Financial Overview

15.2.2.3. Product Portfolio

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

15.2.3. Novartis AG

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Financial Overview

15.2.3.3. Product Portfolio

15.2.3.4. Strategic Overview

15.2.3.5. SWOT Analysis

15.2.4. Merck & Co., Inc.

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Financial Overview

15.2.4.3. Product Portfolio

15.2.4.4. Strategic Overview

15.2.4.5. SWOT Analysis

15.2.5. Johnson & Johnson 

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Financial Overview

15.2.5.3. Product Portfolio

15.2.5.4. Strategic Overview

15.2.5.5. SWOT Analysis

15.2.6. Pfizer, Inc. 

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Financial Overview

15.2.6.3. Product Portfolio

15.2.6.4. Strategic Overview

15.2.6.5. SWOT Analysis

15.2.7. AstraZeneca plc 

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Financial Overview

15.2.7.3. Product Portfolio

15.2.7.4. Strategic Overview

15.2.7.5. SWOT Analysis

15.2.8. AbbVie, Inc. 

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Financial Overview

15.2.8.3. Product Portfolio

15.2.8.4. Strategic Overview

15.2.8.5. SWOT Analysis

15.2.9. LEO Pharma A/S 

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Financial Overview

15.2.9.3. Product Portfolio

15.2.9.4. Strategic Overview

15.2.9.5. SWOT Analysis

15.2.10. Biogen, Inc.

15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.10.2. Financial Overview

15.2.10.3. Product Portfolio

15.2.10.4. Strategic Overview

15.2.10.5. SWOT Analysis

List of Table

List of Tables

Table 01: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 02: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 03: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 04: Global Psoriasis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 06: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 07: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 08: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 10: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 11: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 12: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 14: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 15: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 16: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 18: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 19: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 20: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 22: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 23: Middle East & Africa Psoriasis Treatment Market Value(US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 24: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Chart

List of Figures

Figure 01: Global Psoriasis Treatment Market Snapshot, 2018

Figure 02: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2017–2027

Figure 04: Global Psoriasis Treatment Market Value Share, by Route of Administration, 2018

Figure 06: Global Psoriasis Treatment Market Value Share, by Region, 2018

Figure 03: Global Psoriasis Treatment Market Value Share, by Drug Class, 2018

Figure 05: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2018

Figure 07: Regulatory Approval Process - U.S. 

Figure 08: Regulatory Approval Process - Europe 

Figure 09: Regulatory Approval Process - Japan

Figure 10: Global Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 11: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TNF Inhibitors, 2017–2027

Figure 12: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Interleukin Inhibitors, 2017–2027

Figure 13: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin D Analogs, 2017–2027

Figure 14: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017–2027

Figure 15: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 16: Global Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 17: Global Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 18: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027

Figure 19: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2017–2027

Figure 20: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2017–2027

Figure 21: Global Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 22: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 23: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 24: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 25: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 26: Global Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 27: Global Psoriasis Treatment Market Value Share, by Region, 2018 and 2027

Figure 28: Global Psoriasis Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 29: North America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 30: North America Psoriasis Treatment Market Attractiveness Analysis, by Country, 2019–2027

Figure 31: North America Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 32: North America Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 33: North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 34: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 35: North America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 36: North America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 37: North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 38: Europe Psoriasis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 39: Europe Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 40: Europe Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 41: Europe Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 42: Europe Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 43: Europe Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration

Figure 44: Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 45: Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 46: Europe Psoriasis Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 47: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 48: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 49: Asia Pacific Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 50: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 51: Asia Pacific Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 52: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 53: Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 54: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 55: Asia Pacific Psoriasis Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 56: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 57: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 58: Latin America Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 59: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 60: Latin America Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 61: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration

Figure 62: Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 63: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel

Figure 64: Latin America Psoriasis Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 65: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 66: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 67: Middle East & Africa Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 68: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 69: Middle East & Africa Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 70: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 71: Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 72: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 73: Middle East & Africa Market Value Share, by Country/Sub-region, 2018 and 2027

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *